Fundamental dimension Equity attribute | ARLLeader $16.30▼-0.67% Cap $263.3MP/E 31.6x QuantScore59/100 | ACREPeer $3.35▲+2.76% Cap $185.9MP/E -44.5x QuantScore35/100 | BRTPeer $13.24▲+0.23% Cap $248.8MP/E -18.9x QuantScore43/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
62/100 |
15/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 86/100 | 47/100 | 68/100 |
Health Piotroski, Altman Z, leverage & liquidity | 48/100 | 7/100 | 7/100 |
Growth Revenue / earnings growth & margins | 39/100 | 52/100 | 14/100 |
Sentiment Analyst ratings, targets & revisions | — | 53/100 | 78/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 31.6x | -44.5x | -18.9x |
Forward P/E (next FY) | — | 13.0x | -17.8x |
EV / EBITDA (TTM) | 13.3x | 28.1x | 19.3x |
Price / Sales | 5.2x | 1.9x | 2.5x |
Price / Free Cash Flow | -31.7x | 14.1x | 23.4x |
PEG ratio | 0.12 | 0.00 | 0.58 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 4 / 9 | 4 / 9 |
Altman Z-Score | 1.86 (Grey) | -0.18 (Distress) | 0.29 (Distress) |
Total debt / equity | 0.35 | 2.58 | 3.17 |
Quick ratio | 15.7x | 0.2x | — |
Interest coverage | -1.0x | 0.4x | 0.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +5.7% | +22.5% | +1.5% |
Net income growth YoY | +206.8% | +97.4% | -22.0% |
Gross margin (TTM) | -39.6% | 71.6% | 28.0% |
Operating margin (FY) | -12.9% | 72.4% | 11.4% |
FCF margin (FY) | -11.1% | 23.1% | 6.8% |
5. Trailing price performancePrice change over period |
1M return | +3.6% | -19.3% | -3.4% |
3M return | +10.2% | -26.4% | -11.7% |
6M return | +12.4% | -36.3% | -7.1% |
Year to date | +1.5% | -29.9% | -9.9% |
1Y return | +5.8% | -27.8% | -11.8% |
3Y return | +29.1% | -63.1% | -21.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $46.06 +182.6% upside | $-11.48 -442.6% premium | $63.20 +377.3% upside |
Wall Street consensus target | — — | $5.50 +64.2% · range $5.50–$5.50 | $21.00 +58.6% · range $21.00–$21.00 |
Consensus stance | — | 36% Buy43% Hold21% Sell | 80% Buy20% Hold0% Sell |